Cargando…
Methotrexate in inflammatory bowel disease: A primer for gastroenterologists
Methotrexate is an antineoplastic agent that is also used at lower doses for anti-inflammatory properties. Along with thiopurines (azathioprine and 6-mercaptopurine), it has historically been an important part of pharmacological treatment for patients with inflammatory bowel disease. Despite an incr...
Autores principales: | AlAmeel, Turki, Al Sulais, Eman, Raine, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408741/ https://www.ncbi.nlm.nih.gov/pubmed/35042318 http://dx.doi.org/10.4103/sjg.sjg_496_21 |
Ejemplares similares
-
Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
por: Al Sulais, Eman, et al.
Publicado: (2020) -
Undisclosed payments by pharmaceutical manufacturers to authors of inflammatory bowel disease guidelines in the United States
por: Al Sulais, Eman, et al.
Publicado: (2021) -
Barriers to research productivity among gastroenterologists and hepatologists in Saudi Arabia
por: AlSardi, Mais, et al.
Publicado: (2020) -
The Prevalence of Irritable Bowel Syndrome Among Board-Certified Medical Doctors In Saudi Arabia: A Cross-sectional Study
por: AlAmeel, Turki, et al.
Publicado: (2019) -
Risk of neutropenia in inflammatory bowel disease patients treated with TNF inhibitors: A single-center, retrospective cohort study
por: AlAskar, Dimah, et al.
Publicado: (2020)